AI assistant
Sending…
Alligator Bioscience — Major Shareholding Notification 2022
Oct 12, 2022
3138_iss_2022-10-12_4fda1972-7c1e-44db-b433-dc6a07d375ee.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Alligator Bioscience AB
Holder
Roxette Photo SA Roxette Photo SA
Instrument
| Instrument | Aktier SE0000767188 | |
|---|---|---|
| Before the transaction | ||
| Shares | 4,804,788 | |
| Voting rights | 4,804,788 | |
| Transaction | ||
| Date | 11/10/2022 | |
| Limit for number of shares 5 % | ||
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 18,413,950 |
| Directly held voting rights 18,413,950 | |
|---|---|
| Indirectly held voting rights 0 | |
Percentage
Directly held shares 8.31 % Directly held voting rights 8.31 % Indirectly held voting rights 0 %
Resulting distribution of total
| holdings | ||
|---|---|---|
| Percentage of voting rights: |
Number of underlying shares: |
|
| Shares | 8.31 % | 18,413,950 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 8.31 % | 18,413,950 |
Notes (other relevant informations according to law)
Köp av aktier från Omentum S.A. pga likvidering av Omentum. Roxette Photo och Omentum har samma Ultimate Beneficial Owners.
Published
12/10/2022 15:49
Contact
Name Maria-Pia Bengtsson Phone 0709795939 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Alligator Bioscience
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Quarterly Report
2026
May 5
Quarterly Report
2026
May 5
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Board/Management Information
2026
Mar 27
Board/Management Information
2026
Mar 27